Centene Co. (NYSE:CNC) Shares Purchased by Diversify Wealth Management LLC

Diversify Wealth Management LLC increased its holdings in shares of Centene Co. (NYSE:CNC) by 44.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,407 shares of the company’s stock after purchasing an additional 2,876 shares during the quarter. Diversify Wealth Management LLC’s holdings in Centene were worth $582,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Intech Investment Management LLC acquired a new stake in Centene in the second quarter valued at approximately $325,000. AE Wealth Management LLC grew its position in Centene by 41.0% in the second quarter. AE Wealth Management LLC now owns 26,142 shares of the company’s stock valued at $1,733,000 after acquiring an additional 7,602 shares in the last quarter. Pacer Advisors Inc. grew its position in Centene by 25.0% in the second quarter. Pacer Advisors Inc. now owns 52,348 shares of the company’s stock valued at $3,471,000 after acquiring an additional 10,453 shares in the last quarter. ProShare Advisors LLC grew its position in Centene by 9.2% in the second quarter. ProShare Advisors LLC now owns 100,489 shares of the company’s stock valued at $6,662,000 after acquiring an additional 8,505 shares in the last quarter. Finally, Frank Rimerman Advisors LLC grew its position in shares of Centene by 21,633.3% during the second quarter. Frank Rimerman Advisors LLC now owns 6,520 shares of the company’s stock worth $432,000 after buying an additional 6,490 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Insider Buying and Selling at Centene

In related news, Director Thomas Greco acquired 17,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 18th. The shares were acquired at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the purchase, the director now directly owns 19,309 shares in the company, valued at $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director H James Dallas acquired 1,693 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were bought at an average price of $59.01 per share, for a total transaction of $99,903.93. Following the completion of the purchase, the director now owns 1,693 shares of the company’s stock, valued at approximately $99,903.93. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 45,010 shares of company stock worth $2,660,276. 0.29% of the stock is owned by insiders.

Centene Stock Performance

CNC stock opened at $63.68 on Wednesday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The stock has a market capitalization of $32.15 billion, a price-to-earnings ratio of 11.06, a PEG ratio of 0.83 and a beta of 0.45. Centene Co. has a 1 year low of $55.03 and a 1 year high of $81.42. The stock’s fifty day moving average is $60.15 and its two-hundred day moving average is $67.30.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on CNC shares. JPMorgan Chase & Co. reissued an “overweight” rating and set a $75.00 price target (down previously from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Barclays raised their price target on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research report on Friday, December 13th. Oppenheimer decreased their price target on shares of Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, December 13th. Truist Financial decreased their price target on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research report on Friday, December 13th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $90.00 price objective on shares of Centene in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $80.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.